PSS34 - COST-EFFECTIVENESS OF INTRAVITREAL AFLIBERCEPT VERSUS RANIBIZUMAB IN THE TREATMENT OF DIABETIC MACULAR EDEMA IN SPAIN
Abstract
Authors
M. Granell Villalon M. Riera A. Boixadera A. Villacampa J. Mondejar C. Deschaseaux